Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MC5R | P33032 | 2/20 | 0.79 |
| ▸ | MC3R | P41968 | 2/20 | 0.79 |
| ▸ | MC1R | Q01726 | 2/20 | 0.79 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.72 |
| ▸ | HTR2A | P28223 | 4/20 | 0.68 |
| ▸ | G6PD | P11413 | 1/20 | 0.64 |
| ▸ | HTR6 | P50406 | 3/20 | 0.64 |
| ▸ | HTR1A | P08908 | 2/20 | 0.64 |
| ▸ | DRD2 | P14416 | 1/20 | 0.64 |
| ▸ | HTR7 | P34969 | 1/20 | 0.64 |
| ▸ | MEN1 | O00255 | 1/20 | 0.63 |
| ▸ | LMNA | P02545 | 1/20 | 0.63 |
| ▸ | TP53 | P04637 | 1/20 | 0.63 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.62 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.62 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.62 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.62 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.62 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.62 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11188453 | 0.98 | MC5R (0.77) | MC5RMC3RMC1RKMT2AHTR2A | |
| Cyanide SCHEMBL30873705 | 0.96 | MC5R (0.73) | MC5RMC3RMC1RKMT2AHTR2A | |
| SCHEMBL23745517 | 0.91 | MC5R (0.71) | MC5RMC3RMC1RKMT2AHTR2A | |
| Hydrochloric Acid SCHEMBL23722207 | 0.90 | MC5R (0.69) | MC5RMC3RMC1RKMT2AHTR2A | |
| SCHEMBL6635277 | 0.90 | SLC6A4 (0.67) | MC5RMC3RMC1RKMT2AHTR2A | |
| SCHEMBL6165432 | 0.89 | MC5R (0.71) | MC5RMC3RMC1RKMT2AHTR2A | |
| SCHEMBL798249 | 0.89 | MC1R (1.00) | MC5RMC3RMC1RKMT2AHTR2A | |
| SCHEMBL18088393 | 0.88 | MC5R (0.71) | MC5RMC3RMC1RKMT2AHTR2A | |
| SCHEMBL6037918 | 0.88 | MC5R (0.71) | MC5RMC3RMC1RKMT2AHTR2A | |
| SCHEMBL17117861 | 0.88 | MC5R (0.71) | MC5RMC3RMC1RKMT2AHTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117164504-A | Indole compound and preparation method and application thereof | 贵州省天然产物研究中心 | 2023-12-05 | — | — | CN | claimed |
| CN-114853820-A | Ferrocene and camphorsulfonic acid composite derivative, preparation method thereof and application thereof in catalyzing asymmetric P-S reaction | 江苏医药职业学院 | 2022-08-05 | — | — | CN | claimed |
| CN-104530047-A | Canthium dicoccum-6-one quaternary ammonium salt and preparation method and applicaton thereof | UNIV NORTHWEST A&F | 2015-04-22 | — | — | CN | claimed |
| US-20260138947-A1 | BENZYLTRYPTAMINE COMPOUNDS | REUNION NEUROSCIENCE INC (US) | 2026-05-21 | — | — | US | disclosed |
| US-20260138947-A1 | BENZYLTRYPTAMINE COMPOUNDS | REUNION NEUROSCIENCE INC (US) | 2026-05-21 | — | — | US | disclosed |
| US-20260042735-A1 | BENZYLTRYPTAMINE COMPOUNDS | REUNION NEUROSCIENCE INC (US) | 2026-02-12 | — | — | US | disclosed |
| US-20260042735-A1 | BENZYLTRYPTAMINE COMPOUNDS | REUNION NEUROSCIENCE INC (US) | 2026-02-12 | — | — | US | disclosed |
| EP-4423061-A4 | NOVEL BENZYLTRYPTAMINE COMPOUNDS | REUNION NEUROSCIENCE INC (US) | 2025-09-10 | — | — | EP | disclosed |
| US-20240400510-A1 | NOVEL BENZYLTRYPTAMINE COMPOUNDS | REUNION NEUROSCIENCE INC (US) | 2024-12-05 | — | — | US | disclosed |
| US-20240400510-A1 | NOVEL BENZYLTRYPTAMINE COMPOUNDS | REUNION NEUROSCIENCE INC (US) | 2024-12-05 | — | — | US | disclosed |
| EP-4423061-A1 | NOVEL BENZYLTRYPTAMINE COMPOUNDS | Reunion Neuroscience, Inc. (US) | 2024-09-04 | — | — | EP | disclosed |
| WO-2008046232-A1 | AZIRIDINE ALDEHYDES, AZIRIDINE-CONJUGATED AMINO DERIVATIVES, AZIRIDINE-CONJUGATED BIOMOLECULES AND PROCESSES FOR THEIR PREPARATION | YUDIN ANDREI K (CA) | 2008-04-24 | — | — | WO | disclosed |
| US-4843080-A | VASODILATION; CARDIOVASCULAR ACTIVITY; CHEMICAL INTERMEDIATES | RICHTER GEDEON VEGYESZETI GYAR RT. (HU) | 1989-06-27 | — | — | US | disclosed |
| EP-0187122-A2 | 1,3,4-Trisubstituted azacycloalkanes or azacycloalkenes | CIBA-GEIGY AG (CH) | 1986-07-09 | — | — | EP | disclosed |
| US-4524073-A | β-Lactam compounds | BEECHAM GROUP P.1.C. (GB) | 1985-06-18 | — | — | US | disclosed |
| EP-0101199-A1 | Beta-lactam compounds | BEECHAM GROUP PLC (GB) | 1984-02-22 | — | — | EP | disclosed |
| US-4425351-A | ANTIANOXIC | SYNTHELABO (FR) | 1984-01-10 | — | — | US | disclosed |
| EP-0089926-A2 | Pharmaceutical preparations of tetracycles containing nitrogen, and compounds of this type | CIBA-GEIGY AG (CH) | 1983-09-28 | — | — | EP | disclosed |
| US-4367230-A | ANTIANOXIC AGENTS | TANABE SEIYAKU CO., LTD. (JP) | 1983-01-04 | — | — | US | disclosed |
| US-4228168-A | ANTI-ANOXIC ACTIVITY | TANABE SEIYAKU CO., LTD. (JP) | 1980-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240400510-A1 | NOVEL BENZYLTRYPTAMINE COMPOUNDS | HTR2C, HTR2A, HTR3B | MC5R 152/4885MC3R 169/4885MC1R 505/4885 |
| US-20260042735-A1 | BENZYLTRYPTAMINE COMPOUNDS | HTR2C, HTR2A, HTR6 | MC5R 52/4885MC3R 137/4885MC1R 579/4885 |
| US-20260138947-A1 | BENZYLTRYPTAMINE COMPOUNDS | HTR2C, CNR2, HTR3B | MC5R 80/4885MC3R 149/4885MC1R 603/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.